Does Medicare Cover Ozempic? (2026)

The Short Answer

PIN IT

Does Medicare cover Ozempic? Yes for type 2 diabetes, no for weight loss — that split is the entire 2026 answer. If you are asking as a diabetes patient, your Part D plan can cover Ozempic. If you are asking in order to lose weight, no pathway pays for Ozempic itself: it has no FDA weight-loss approval (its label is type 2 diabetes), it is not one of the three Medicare GLP-1 Bridge drugs, and federal law still excludes weight-loss drugs from Part D everywhere else.

The part most people miss: Ozempic’s active ingredient, semaglutide, carries an FDA weight-loss label when it is sold as Wegovy — and Wegovy is a Bridge drug, for people who qualify. This page shows you whether you do, and what to ask your doctor for instead.

One Ingredient, Three Labels

Semaglutide is one molecule sold under three brand names, and Medicare treats each one as a separate product with its own rulebook.

Say your doctor mentions “semaglutide for weight”: the prescription Medicare can actually help with is Wegovy, not Ozempic. The label is everything to Medicare. Wegovy’s heart-risk indication, approved by the FDA in March 2024, is also why some Part D plans cover Wegovy for that specific reason, plan by plan. The brand-level walkthrough lives in our does Medicare cover Wegovy guide.

When Medicare Pays for Ozempic

Ozempic is a covered Part D drug for type 2 diabetes, and that lane works the way Part D usually works. Most plans require prior authorization — most, not all, so check yours — and step therapy is common, usually metformin first. Costs depend entirely on your plan’s deductible and coinsurance; there is no universal dollar figure.

And if you searched does Medicare cover Ozempic for weight loss because you already take it for diabetes, the answer is still no — and the Bridge is closed to you as well. Anyone who can already get a GLP-1 through their Part D plan is locked out of the Bridge by design; diabetes coverage never converts into weight-loss coverage.

Your Real Weight-Loss Options

The door Medicare left open is the Medicare GLP-1 Bridge, a temporary CMS demonstration that launched July 1, 2026 and runs through December 31, 2027. It is not a permanent benefit, and it is not run by your drug plan — claims go through a CMS central processor, and problems go to 1-800-MEDICARE. The full program walkthrough lives in our main Medicare weight-loss drug coverage guide.

Only three drugs are in the program, each at a flat $50 per one-month supply, regardless of income or dose:

• Foundayo (orforglipron) — Eli Lilly’s daily tablet and the only GLP-1 pill in the program, FDA-approved April 1, 2026.
• Wegovy (semaglutide) — injection or tablet; the weight-loss form of the Ozempic ingredient.
• Zepbound (tirzepatide) — KwikPen only. Single-dose pens and vials are not covered, so check the form on your prescription.

Eligibility is all-or-nothing: Medicare’s own beneficiary fact sheet lists four requirements, and you need all four.

1. You have Part D drug coverage — a standalone drug plan or a Medicare Advantage plan that includes drugs. Private fee-for-service, cost, and PACE-only plans do not count.
2. You cannot already get a GLP-1 through your plan. If your plan covers one for you for any reason, the Bridge is closed to you.
3. You do not have type 2 diabetes, moderate-to-severe sleep apnea, or the liver condition MASH. Those diagnoses route you to regular Part D coverage instead.
4. You are 18 or older and meet a BMI tier: 35 or higher on its own; 30 or higher with certain heart failure, hard-to-control high blood pressure, or chronic kidney disease stage 3a or later; or 27 or higher with prediabetes or a prior heart attack, stroke, or blocked arteries in the legs or arms.

Say you are 68 with a BMI of 31 and blood pressure that stays high on two medications: you qualify under the second tier. Say your BMI is 28 and your only diagnosis is high cholesterol: you do not qualify — the 27 tier needs prediabetes or heart-and-artery history.

There is no sign-up form and nothing to enroll in. Your doctor sends a prior-authorization request to Medicare’s central processor, you get a confirmation letter, and you pick up the prescription for $50. Refills of the same drug need no new paperwork, even when the dose changes; switching drugs starts a new request. Check the rules at Medicare.gov/glp1bridge or by calling 1-800-MEDICARE.

Drug-by-Drug Snapshot

Where each drug stands as of July 2026 — cash prices are manufacturer program prices and change often.

What It Actually Costs

The Bridge price is genuinely flat: $50 per month per prescription, whatever your income, whatever the dose. But the program sits outside Part D, and that design has consequences.

• Your $50 copays never count toward your Part D deductible (up to $615 in 2026) or the $2,100 annual out-of-pocket cap — and it is $2,100 this year, not 2025’s $2,000.
• Extra Help does not reduce the $50, coupons cannot be applied, and the Medicare Prescription Payment Plan cannot spread it out.
• In the diabetes lane, Ozempic costs follow your plan’s rules — deductible, then coinsurance, up to the cap. Those payments do count toward the $2,100.

Do not qualify? The cash programs in the table above are the fallback.

The 2027 Cliff

Why did this change in 2026? A late-2024 proposal to cover weight-loss drugs outright was never finalized, but after White House pricing deals with Novo Nordisk and Eli Lilly in late 2025, CMS announced the Bridge in May 2026 and switched it on July 1, 2026. The statutory exclusion never moved — the Bridge is layered on top of it, temporarily.

The demonstration ends December 31, 2027, and no successor has been announced. Every month you wait is a covered month you do not get back — and it is worth making a 2028 plan with your doctor either way.

FAQs

Quick answers on whether Medicare covers Ozempic:

The questions readers send after the no.

1. Does Medicare cover Ozempic for weight loss under any rule?

People asking about Ozempic for weight loss are usually hoping for a loophole, and in 2026 there is none. Ozempic carries no FDA weight-loss approval, it is not on the Bridge drug list, and the statutory exclusion blocks every other route. The covered path to semaglutide for weight loss runs through Wegovy instead.

2. Can I get Wegovy instead of Ozempic through Medicare?

Wegovy is where this search usually should have started. The honest answer to does Medicare cover Ozempic is that you were asking about the wrong brand name. Wegovy is the same active ingredient with an FDA weight-loss label, it is a Bridge drug at $50 a month, and your doctor can request it.

3. Does Medicare cover Ozempic if I have prediabetes instead of type 2 diabetes?

Prediabetes changes the answer in a surprisingly helpful way. It does not unlock Ozempic itself, but it lowers the Bridge eligibility bar: with prediabetes you can qualify at a BMI of 27 or higher. Full type 2 diabetes works the opposite way and excludes you from the Bridge entirely.

4. Does the $50 Bridge copay count toward my $2,100 cap?

The Bridge operates outside Part D, which surprises many people researching does Medicare cover Ozempic. Your $50 copays never count toward the $615 maximum deductible or the $2,100 out-of-pocket cap, Extra Help does not lower them, and the Medicare Prescription Payment Plan cannot spread them out. Treat the $50 as a separate expense.

5. Does Medicare cover Ozempic for weight loss if my doctor prescribes it off-label?

A prescription cannot override coverage rules, so the plain answer is no. Part D pays for Ozempic only for approved uses, chiefly type 2 diabetes, and the Bridge pays only for its three listed drugs. Off-label Ozempic for weight reduction means paying the full list price yourself — roughly $1,000 a month at mid-2026 prices.

6. How does Medicare handle Ozempic for type 2 diabetes?

Part D plans do cover Ozempic for type 2 diabetes, which is why does Medicare cover Ozempic confuses so many households. Most plans require prior authorization, and many ask you to try metformin first. Those costs follow your plan’s deductible and coinsurance, and unlike Bridge copays they do count toward the $2,100 cap.

7. Does Medicare cover Ozempic once the Bridge ends in December 2027?

The demonstration runs through December 31, 2027, and nothing announced so far replaces it. After that date, the answer stays no for weight loss, and the Wegovy pathway loses its $50 program too. If you qualify now, starting sooner buys more covered months, and your doctor can help you plan the transition.

My Bottom Line

So, does Medicare cover Ozempic for weight loss? No — not in 2026, and nothing on the calendar changes that. But the ingredient you were asking about is covered, at $50 a month, under a different name and a strict set of rules.

If the prescription says Wegovy, start with our Wegovy Medicare guide. For the whole program — eligibility, paperwork, the 2027 deadline — the main Medicare weight-loss drug coverage guide covers it end to end.

Resources

• CMS: Medicare GLP-1 Bridge (official page)
• CMS: Bridge launch press release
• Medicare.gov: official Bridge fact sheet (PDF 12234)
• CMS: CY 2026 Part D redesign instructions
• FDA: Wegovy heart-risk approval
• Eli Lilly: Foundayo (orforglipron) FDA approval